FDA Advises Sponsor-Investigators on Submitting INDs

Drug Industry Daily
A A
The FDA has issued draft guidance spelling out in detail how to prepare and submit an IND if the sponsor is an investigator and not a commercial entity — saying sponsor-investigators often lack the regulatory know-how to submit a proper IND.

To View This Article:

Login

Subscribe To Drug Industry Daily